Skip to main content
Fig. 4 | Allergy, Asthma & Clinical Immunology

Fig. 4

From: Immunoglobulin replacement therapy in patients with immunodeficiencies: impact of infusion method on patient-reported outcomes

Fig. 4

Respondent symptom state and perceived health status in the SCIg and IVIg cohorts. A Proportion of respondents who responded ‘affirmative’ to whether they were at an acceptable symptom state (measured using PASS) and B proportion of respondents who described their current health status as ‘fair’, ‘good’, ‘very good’ or ‘excellent’ (measured using GHP). The complementary response category for PASS was ‘negative’ and for GHP were ‘poor’ or ‘very poor’. Significant p-values are highlighted in bold. GHP general health perception, IVIg intravenous immunoglobulin, PASS patient acceptable symptom state, SCIg subcutaneous immunoglobulin

Back to article page